← All indications
Edema
Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE.
Subtype terms (2)
More specific conditions that are subtypes of Edema in the MeSH hierarchy.
- Edema, Cardiac
2 drugs (1 approved, 1 experimental)
- Hydrops Fetalis
1 drug experimental
Drugs by status
Approved for this indication (14)
Phase 4 trials (20)
Phase 3 trials (5)
Phase 2 trials (20)
Phase 1 trials (5)
Other trials (30)
- diclofenac
- melatonin
- vitamin d3
- arnica
- human fibrin
- chondroitin
- leukocytes
- mepivacaine
- valsartan
- platelet rich fibrin
- hyaluronic acid
- lercanidipine
- triamcinolone
- budesonide
- anacaulase
- etodalac
- tromethamine
- oxygen
- horse chestnut
- codeine
- diosmetine
- etoricoxib
- hesperidin
- dextrose
- heparinoids
- khat
- Dexketoprofen
- concentrated growth factor
- sodium aescinate
- escin
Organizations
Organization Involved with Phase 4 Indications (107)
- Alimera Sciences
- Regeneron
- Genentech
- Alcon
- Novartis
- Allergan
- Bayer
- Bp Consulting, Inc
- Carolina Eyecare Physicians, LLC
- GWT-TUD GmbH
- LUTRONIC Corporation
- SironRX Therapeutics, Inc.
- Southeast Clinical Research Associates, LLC
- The EMMES Corporation
- Fundación Canaria Rafael Clavijo para la Investigación Biomédica
- National Eye Institute (NEI)
- Bay Area Retina Associates
- Cairo University
- California Retina Consultants
- Center For Excellence In Eye Care
- Ciusss de L'Est de l'Île de Montréal
- Dong-A University
- Indiana University
- Inje University
- King Khaled Eye Specialist Hospital
- Johns Hopkins University
- Korea University
- Kosin University
- Kyorin University
- Kyoto University
- +77 more
Organization Involved with Phase 3 Indications (74)
- Bausch & Lomb
- Mylan
- Ampio Pharmaceuticals. Inc.
- Santen Inc.
- Celtic Pharma Development Services
- Chengdu Kanghong Biotech Co.,Ltd.
- Chromaderm, Inc.
- Clearside Biomedical, Inc.
- Crolll Gmbh
- Endo Pharmaceuticals
- Hamilton Health Sciences Corporation
- Neurobiological Technologies
- Remedy Pharmaceuticals, Inc.
- Otsuka
- Rudolf Foundation Clinic
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- National Institutes of Health (NIH)
- The Hospital for Sick Children
- Shahid Beheshti University of Medical Sciences
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Maastricht University
- Barrow Neurological Institute
- Changhai Hospital
- University of London
- Harvard University
- Hospital Son Espases
- Julius-Maximilians University
- Jaeb Center for Health Research
- King Saud University
- McMaster University
- +44 more
Organization Involved with Phase 2 Indications (97)
- Abbott
- Astellas
- Adverum Biotechnologies, Inc.
- Merck
- CoMentis
- Allegro Ophthalmics, LLC
- Aerie Pharmaceuticals
- Aerpio Therapeutics
- Eyegate Pharmaceuticals, Inc.
- KalVista Pharmaceuticals, Ltd.
- Opthea Pty Ltd.
- Sanwa Kagaku Kenkyusho Co., Ltd.
- SciFluor Life Sciences, Inc.
- Taiwan Liposome Company
- South Coast Retina Center; Carson, McBeath, Boswell, Inc.
- iCo Therapeutics Inc.
- Boehringer Ingelheim
- Mid-Atlantic Retina Consultations, Inc.
- PharmaNet
- Quark Pharmaceuticals
- Stealth BioTherapeutics Inc.
- Universidad Nacional Autonoma de Mexico
- Hanscom, Thomas, M.D.
- Jumper, J. Michael, M.D.
- Baylor University
- Chang Gung University
- Elman Retina Group
- Especialistas en Retina Medica y Quirurgica Grupo de Investigacion
- Duke University
- Greater Houston Retina Research
- +67 more
Organization Involved with Phase 1 Indications (26)
- GlaxoSmithKline
- LTS Lohmann Therapie-Systeme AG
- River Vision Development Corporation
- Sunshine Lake Pharma Co., Ltd.
- SurModics, Inc.
- SocraTec R&D GmbH
- Molecular Partners AG
- Joslin Diabetes Center
- Kresge Eye Institute
- Ophthalmic Consultants of Boston
- Tanta University
- University of Heidelberg
- University of Miami
- Wake Forest University
- University of Warwick
- Illinois Retina and Eye Associates
- University of Mannheim
- Retina Vitreous Associates Beverley Hills, California
- VitreoRetinal Surgery, PA
- Fountain Medical Development Co., Ltd.
- Divers Alert Network
- Sesen Bio
- UNITY Biotechnology
- Targeted Therapy Technologies, LLC
- MingSight-Relin Pharmaceuticals Co., Ltd.
- Emmecell
Organization Involved with Other Experimental Indications (41)
- Kala Pharmaceuticals, Inc.
- OD-OS GmbH
- Retina Research Institute, LLC
- Fondazione G.B. Bietti, IRCCS
- Allina Health System
- Alexandria University
- Barnes Retina Institute
- Erzincan University
- Eye Clinic Medic Zuljan Jukic
- Mashhad University of Medical Sciences
- Los Angeles Biomedical Research Institute
- Neon Hospital
- Ondokuz Mayıs University
- Retina Clinic, Sao Paulo, Brazil
- Restorix Research Institute, LLLP
- Tufts University
- University of Oklahoma
- University of Zagreb
- Illinois Retina Associates
- Istanbul University
- Renal Research Institute
- Retina Associates, Kansas City
- T.C. Ordu Universitesi
- University of Copenhagen
- Allina Health
- Emek Medical Center
- Allure Laser Center & Medispa
- University of Split
- Dean A. McGee Eye Institute
- University of Western Ontario
- +11 more